Article Text

Download PDFPDF
  1. Richard Lehman, MRCGP, MA
  1. Department of Primary Care, University of Oxford
 Oxford, UK

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Asthma is the oldest medical word in common use: it first appears in the writings of Hippocrates around 450 BCE and derives from a verb used by Homer. Two and a half millennia later, we continue to argue about its definition and treatment. The drugs we prescribe most are the β adrenergic agonists, both short acting and long acting, although they are associated with an increase in the risk of asthma-related death. We urge many patients to take inhaled corticosteroids, but many forget; for them a good idea might be to use metered dose inhalers with an audiovisual reminder device, according to a trial from New Zealand (

    ) . Recently, fixed dose combinations of long acting β stimulants and steroids have become popular with both doctors and patients, though we lack good data on their long term safety. A Polish study compared 2 frequently used combinations, salmeterol/fluticasone and formoterol/budesonide. They performed equally well over 6 months (
    ) . And a study aimed at reducing treatment for mild persistent asthma in the USA …

    View Full Text